Internal Medicine NewsErgonomic consultation spares endoscopists a pain in the neckFebruary 17, 2021Gastroenterology
Internal Medicine NewsCheckpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseasesFebruary 16, 2021OncologyRheumatologyDermatologyGastroenterology
Internal Medicine NewsVedolizumab looks safer than anti-TNF drugs in older adults with IBDFebruary 11, 2021Gastroenterology
Internal Medicine NewsAGA Clinical Practice Update: Bariatric surgery in patients with cirrhosisFebruary 5, 2021HepatologyGastroenterologyObesity
Internal Medicine NewsFDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)February 5, 2021RheumatologyGastroenterologyPulmonology
Internal Medicine NewsAGA Clinical Practice Update: Diagnosis and management of immune checkpoint inhibitor enterocolitis and hepatitisFebruary 4, 2021Gastroenterology
Internal Medicine NewsTofacitinib for RA misses the mark in safety studyFebruary 1, 2021GastroenterologyRheumatology
Internal Medicine NewsHigh cost of pancreatic enzymes a barrier for patients with cancerJanuary 29, 2021Gastroenterology
Internal Medicine NewsIncidence of autoimmune hepatitis may be risingJanuary 29, 2021GastroenterologyDiabetesInfectious Diseases
Internal Medicine NewsCOVID-19 may alter gut microbiotaJanuary 29, 2021COVID-19 UpdatesGastroenterologyMixed Topics
Internal Medicine NewsCombo testing improves CRC screening participation, but not advanced disease detectionJanuary 28, 2021GastroenterologyOncologyPreventive Care
Internal Medicine NewsRacial, social inequities persist in IBDJanuary 27, 2021GastroenterologyDiversity in Medicine
